Logo image of CGBS

CROWN LNG HOLDINGS LTD (CGBS) Stock Fundamental Analysis

NASDAQ:CGBS - Nasdaq - JE00BPSKDR41 - Common Stock - Currency: USD

0.2999  -0.02 (-5.15%)

After market: 0.3099 +0.01 (+3.33%)

Fundamental Rating

0

Overall CGBS gets a fundamental rating of 0 out of 10. We evaluated CGBS against 211 industry peers in the Oil, Gas & Consumable Fuels industry. CGBS may be in some trouble as it scores bad on both profitability and health. CGBS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CGBS has reported negative net income.
CGBS had a negative operating cash flow in the past year.
CGBS Yearly Net Income VS EBIT VS OCF VS FCFCGBS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2020 2021 2022 2023 0 5M -5M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of -39.94%, CGBS is doing worse than 97.56% of the companies in the same industry.
CGBS has a worse Return On Equity (-161.54%) than 93.17% of its industry peers.
Industry RankSector Rank
ROA -39.94%
ROE -161.54%
ROIC N/A
ROA(3y)-4.82%
ROA(5y)N/A
ROE(3y)-11.31%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CGBS Yearly ROA, ROE, ROICCGBS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2020 2021 2022 2023 0 10 -10 -20 -30 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CGBS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CGBS Yearly Profit, Operating, Gross MarginsCGBS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2020 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for CGBS has been reduced compared to 1 year ago.
CGBS has a worse debt/assets ratio than last year.
CGBS Yearly Shares OutstandingCGBS Yearly Shares OutstandingYearly Shares Outstanding 2015 2020 2021 2022 2023 10M 20M 30M
CGBS Yearly Total Debt VS Total AssetsCGBS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

CGBS has an Altman-Z score of -1.79. This is a bad value and indicates that CGBS is not financially healthy and even has some risk of bankruptcy.
CGBS's Altman-Z score of -1.79 is on the low side compared to the rest of the industry. CGBS is outperformed by 76.10% of its industry peers.
A Debt/Equity ratio of 0.93 indicates that CGBS is somewhat dependend on debt financing.
The Debt to Equity ratio of CGBS (0.93) is worse than 72.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF N/A
Altman-Z -1.79
ROIC/WACCN/A
WACCN/A
CGBS Yearly LT Debt VS Equity VS FCFCGBS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2020 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

CGBS has a Current Ratio of 0.22. This is a bad value and indicates that CGBS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.22, CGBS is doing worse than 96.10% of the companies in the same industry.
CGBS has a Quick Ratio of 0.22. This is a bad value and indicates that CGBS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.22, CGBS is doing worse than 94.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
CGBS Yearly Current Assets VS Current LiabilitesCGBS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

CGBS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -617.12%.
EPS 1Y (TTM)-617.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2484.9%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CGBS Yearly Revenue VS EstimatesCGBS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2020 2021 2022 2023
CGBS Yearly EPS VS EstimatesCGBS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CGBS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CGBS Price Earnings VS Forward Price EarningsCGBS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGBS Per share dataCGBS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CGBS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CROWN LNG HOLDINGS LTD

NASDAQ:CGBS (2/11/2025, 7:22:44 PM)

After market: 0.3099 +0.01 (+3.33%)

0.2999

-0.02 (-5.15%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.14%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.85M
AnalystsN/A
Price TargetN/A
Short Float %3%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.99
P/tB 3.99
EV/EBITDA N/A
EPS(TTM)-0.88
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.08
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.94%
ROE -161.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.82%
ROA(5y)N/A
ROE(3y)-11.31%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z -1.79
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-617.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2484.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-317.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-79.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.83%
OCF growth 3YN/A
OCF growth 5YN/A